K
Kurt Ulm
Researcher at Technische Universität München
Publications - 231
Citations - 14785
Kurt Ulm is an academic researcher from Technische Universität München. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 55, co-authored 227 publications receiving 13731 citations. Previous affiliations of Kurt Ulm include Ludwig Maximilian University of Munich.
Papers
More filters
Journal ArticleDOI
A Randomized Comparison of Antiplatelet and Anticoagulant Therapy After the Placement of Coronary-Artery Stents.
Albert Schömig,Franz-Josef Neumann,Adnan Kastrati,Helmut Schühlen,Rudolf Blasini,Martin Hadamitzky,Hanna Walter,Eva-Maria Zitzmann-Roth,Gert Richardt,Eckhard Alt,Claus Schmitt,Kurt Ulm +11 more
TL;DR: Combined antiplatelet therapy after the placement of coronary-artery stents reduces the incidence of both cardiac events and hemorrhagic and vascular complications as compared with conventional anticoagulant therapy.
Journal ArticleDOI
Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction
Georg Schmidt,Marek Malik,Petra Barthel,Raphaël Schneider,Kurt Ulm,Linda M. Rolnitzky,A. John Camm,J. Thomas Bigger,Albert Schömig +8 more
TL;DR: The absence of the heart rate turbulence after ventricular premature beats is a very potent postinfarction risk stratifier that is independent of other known risk factors and which is stronger than other presently available risk predictors.
Journal ArticleDOI
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.
Maxime P. Look,Wim L. J. van Putten,Michael J. Duffy,Nadia Harbeck,Ib Jarle Christensen,Christoph Thomssen,Ronald E. Kates,Frédérique Spyratos,Mårten Fernö,Serenella Eppenberger-Castori,C. G. J. Fred Sweep,Kurt Ulm,J. P. Peyrat,Pierre-Marie Martin,Henri Magdelenat,Nils Brünner,Catherine Duggan,Björn W. Lisboa,Pär-Ola Bendahl,Véronique Quillien,A Daver,Gabriel Ricolleau,Marion E. Meijer-van Gelder,Peggy Manders,W. Edward Fiets,Marinus A. Blankenstein,Philippe Broët,Sylvie Romain,Günter Daxenbichler,Gudrun Windbichler,Tanja Cufer,Simona Borštnar,Willy Kueng,Louk V.A.M. Beex,Jan G. M. Klijn,Niall O'Higgins,Urs Eppenberger,Fritz Jänicke,Manfred Schmitt,John A. Foekens +39 more
TL;DR: For patients with lymph node-negative breast cancer, uPA and PAI-1 measurements in primary tumors may be especially useful for designing individualized treatment strategies.
Journal ArticleDOI
Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study
Axel Bauer,Jan W. Kantelhardt,Petra Barthel,Raphaël Schneider,Timo H. Mäkikallio,Kurt Ulm,Katerina Hnatkova,Albert Schömig,Heikki V. Huikuri,Armin Bunde,Marek Malik,Georg Schmidt +11 more
TL;DR: Impaired heart rate deceleration capacity is a powerful predictor of mortality after myocardial infarction and is more accurate than LVEF and the conventional measures of heart-rate variability.
Journal ArticleDOI
Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic Patients
Alban Dibra,Adnan Kastrati,Julinda Mehilli,Jürgen Pache,Helmut Schühlen,Nicolas von Beckerath,Kurt Ulm,Rainer Wessely,Josef Dirschinger,Albert Schömig +9 more
TL;DR: In patients with diabetes mellitus and coronary artery disease, use of the sirolimus-eluting stent is associated with a decrease in the extent of late luminal loss, as compared withUse of the paclitaxel-eluted stent, suggesting a reduced risk of restenosis.